DiscoverSpondycastBiologic Tapering in axSpA: What Research Says and What it Means for Patients
Biologic Tapering in axSpA: What Research Says and What it Means for Patients

Biologic Tapering in axSpA: What Research Says and What it Means for Patients

Update: 2025-10-29
Share

Description

Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Biologic Tapering in axSpA: What Research Says and What it Means for Patients

Biologic Tapering in axSpA: What Research Says and What it Means for Patients